Literature DB >> 31890457

Anaplastic glioneuronal tumor with KIAA1549/BRAF fusion.

Liqiong Liu1,2, Prithvi Narayan3, Jay Xiong3,4, Zhenggang Xiong2.   

Abstract

Glioneuronal tumors are usually low-grade and have favorable prognosis. The anaplastic glioneuronal tumor with KIAA1549/BRAF fusion has not yet been documented. This article reports a case of glioneuronal tumor with anaplasia and KIAA1549/BRAF fusion to illuminate the importance of KIAA1549/BRAF fusion in high-grade glioneuronal tumors. A ten-year-old boy presented with one year of headache and three months of blurry vision and proptosis. Ophthalmologic evaluation revealed bilateral papilledema. Magnetic resonance imaging showed a large mixed cystic and solid mass in the left frontal lobe of cerebrum. Histologic analysis demonstrated a neoplasm with pseudopapillary growth pattern, focal necrosis, microcalcification, and brisk mitotic activity with a high Ki67 labeling index of focally up to 20%. Immunohistochemical assessment identified a mixed glial and neuronal neoplastic cell population. Molecular studies revealed a KIAA1549/BRAF fusion. The histological and molecular changes are consistent with an anaplastic glioneuronal tumor with KIAA1549/BRAF fusion. In view of the fact that the effective, targeted therapies for the tumors with KIAA1549/BRAF fusion are available, detection of KIAA1549/BRAF fusion for high-grade glioneuronal tumors is clinically helpful. 2019, International Research and Cooperation Association for Bio & Socio - Sciences Advancement.

Entities:  

Keywords:  Glioneuronal tumor; KIAA1549/BRAF fusion; anaplasia; central nervous system

Year:  2019        PMID: 31890457      PMCID: PMC6929590          DOI: 10.5582/irdr.2019.01118

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  14 in total

1.  Pediatric low-grade gliomas can be molecularly stratified for risk.

Authors:  Rui Ryan Yang; Abudumijiti Aibaidula; Wei-Wei Wang; Aden Ka-Yin Chan; Zhi-Feng Shi; Zhen-Yu Zhang; Danny Tat Ming Chan; Wai Sang Poon; Xian-Zhi Liu; Wen-Cai Li; Rui-Qi Zhang; Yan-Xi Li; Nellie Yuk-Fei Chung; Hong Chen; Jingsong Wu; Liangfu Zhou; Kay Ka-Wai Li; Ho-Keung Ng
Journal:  Acta Neuropathol       Date:  2018-06-14       Impact factor: 17.088

Review 2.  BRAF alterations in primary brain tumors.

Authors:  Stefania Maraka; Filip Janku
Journal:  Discov Med       Date:  2018-08       Impact factor: 2.970

3.  Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumors.

Authors:  Marina N Nikiforova; Abigail I Wald; Melissa A Melan; Somak Roy; Shan Zhong; Ronald L Hamilton; Frank S Lieberman; Jan Drappatz; Nduka M Amankulor; Ian F Pollack; Yuri E Nikiforov; Craig Horbinski
Journal:  Neuro Oncol       Date:  2015-12-17       Impact factor: 12.300

4.  Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts.

Authors:  David T W Jones; Shani A Mulholland; Danita M Pearson; Deborah S Malley; Samuel W S Openshaw; Sally R Lambert; Lu Liu; L Magnus Bäcklund; Koichi Ichimura; V Peter Collins
Journal:  Acta Neuropathol       Date:  2011-02-17       Impact factor: 17.088

5.  Raf family kinases: old dogs have learned new tricks.

Authors:  David Matallanas; Marc Birtwistle; David Romano; Armin Zebisch; Jens Rauch; Alexander von Kriegsheim; Walter Kolch
Journal:  Genes Cancer       Date:  2011-03

6.  Interplay among BRAF, p16, p53, and MIB1 in pediatric low-grade gliomas.

Authors:  Craig Horbinski; Marina N Nikiforova; Jill M Hagenkord; Ronald L Hamilton; Ian F Pollack
Journal:  Neuro Oncol       Date:  2012-04-05       Impact factor: 12.300

7.  Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas.

Authors:  Angela J Sievert; Shih-Shan Lang; Katie L Boucher; Peter J Madsen; Erin Slaunwhite; Namrata Choudhari; Meghan Kellet; Phillip B Storm; Adam C Resnick
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-26       Impact factor: 11.205

8.  Molecular Profiling of a Rare Rosette-Forming Glioneuronal Tumor Arising in the Spinal Cord.

Authors:  Lucas Tadeu Bidinotto; Cristovam Scapulatempo-Neto; Alan Mackay; Gisele Caravina de Almeida; Bernd Walter Scheithauer; Gustavo Noriz Berardinelli; Raul Torrieri; Carlos Afonso Clara; Leonir Terezinha Feltrin; Marta Viana-Pereira; Marileila Varella-Garcia; Chris Jones; Rui Manuel Reis
Journal:  PLoS One       Date:  2015-09-15       Impact factor: 3.240

9.  Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation Signatures.

Authors:  Adrienne Johnson; Eric Severson; Laurie Gay; Jo-Anne Vergilio; Julia Elvin; James Suh; Sugganth Daniel; Mandy Covert; Garrett M Frampton; Sigmund Hsu; Glenn J Lesser; Kimberly Stogner-Underwood; Ryan T Mott; Sarah Z Rush; Jennifer J Stanke; Sonika Dahiya; James Sun; Prasanth Reddy; Zachary R Chalmers; Rachel Erlich; Yakov Chudnovsky; David Fabrizio; Alexa B Schrock; Siraj Ali; Vincent Miller; Philip J Stephens; Jeffrey Ross; John R Crawford; Shakti H Ramkissoon
Journal:  Oncologist       Date:  2017-09-14

10.  Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas.

Authors:  David T W Jones; Sylvia Kocialkowski; Lu Liu; Danita M Pearson; L Magnus Bäcklund; Koichi Ichimura; V Peter Collins
Journal:  Cancer Res       Date:  2008-11-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.